ESRRA and prostate cancer: Furthermore, PGC1α also affects estrogen‐related receptor (ERRα)‐related signaling; the PGC1α–ERRα axis is repressed in prostate cancer, and this axis has potential tumor‐suppressive effects and downregulates Myc [178].